Daily BriefsSingapore

Daily Brief Singapore: Envictus International Holdings, Scilex Holding and more

In today’s briefing:

  • 10 in 10 with Envictus International – 20 Years of Texas Chicken and More
  • SCLX: Product Gets FDA Approval and Hits Market


10 in 10 with Envictus International – 20 Years of Texas Chicken and More

By Geoff Howie

10 in 10 with Envictus International – 20 Years of Texas Chicken and More

SCLX: Product Gets FDA Approval and Hits Market

By Zacks Small Cap Research

  • SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products.
  • The company already has commercialized products that are proven to improve patients’ lives.
  • The company recently added to its important line on non-opioid drugs by announcing the FDA approved the commercial manufacturing of Gloperba and that the product is being stocked in many national pharmacy chains and independent pharmacies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars